NCT05642923View on ClinicalTrials.gov

Post-COVID-19 Chronic Fatigue Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

528

Participants

Timeline

Start Date

January 8, 2023

Primary Completion Date

June 1, 2024

Study Completion Date

March 5, 2025

Conditions
Post-COVID-19 SyndromePost-COVID Syndrome
Interventions
DRUG

Synthetic Vitamin B1

Synthetic Vitamin B1 400 mg per day

Trial Locations (1)

11433

Asalam, Maadi

Sponsors

Lead Sponsor

ClinAmygate
All Listed Sponsors
collaborator

As-Salam Center, Maadi, Cairo, Egypt

UNKNOWN

lead

ClinAmygate

OTHER

NCT05642923 - Post-COVID-19 Chronic Fatigue Syndrome | Biotech Hunter | Biotech Hunter